Pharmacy News Articles

▼ Show details

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Interaction between digoxin and dronedarone in the pallas trial Circulation: Arrhythmia and Electrophysiology, December 19, 2014    Clinical Article

2 Alitretinoin for the treatment of severe chronic hand eczema Full Text Patient Preference and Adherence, December 19, 2014    Review Article

3 Randomized phase II trial of gemcitabine plus TH-302 versus gemcitabine in patients with advanced pancreatic cancer Journal of Clinical Oncology, December 19, 2014    Clinical Article

4 Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients Clinical Infectious Diseases, December 19, 2014    Clinical Article

5 Between paradoxical decrease in high-density lipoprotein cholesterol levels following statin therapy and adverse cardiovascular events in patients with acute myocardial infarction The American Journal of Cardiology, December 19, 2014    Clinical Article

6 A cluster-randomized controlled trial of a multicomponent intervention protocol for pneumonia prevention among nursing home elders Clinical Infectious Diseases, December 19, 2014    Clinical Article

7 Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol Full Text BMC Infectious Diseases, December 19, 2014    Clinical Article

8 Effect of combining tramadol and morphine in adult surgical patients: a systematic review and meta-analysis of randomized trials British Journal of Anesthesia, December 19, 2014    Clinical Article

9 Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancer Annals of Pharmacotherapy, December 19, 2014    Review Article

10 Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer European Journal of Cancer, December 19, 2014    Clinical Article

11 Lmax and imiquimod 3.75% in daily clinical practice Journal of the European Academy of Dermatology and Venereology, December 19, 2014    Clinical Article

12 Effect of individually tailored biopsychosocial workplace interventions on chronic musculoskeletal pain, stress and work ability among laboratory technicians: randomized controlled trial protocol Full Text BMC Musculoskeletal Disorders, December 19, 2014    Evidence Based Medicine

13 Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke Thrombosis Research, December 19, 2014    Clinical Article

14 Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factors Ophthalmologica, December 19, 2014    Clinical Article

15 Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration Ophthalmology, December 19, 2014    Clinical Article

16 FDA approves Amgen drug for acute lymphoblastic leukemia Full Text BioPharm International, December 19, 2014

17 Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors Cancer Chemotherapy and Pharmacology, December 19, 2014    Clinical Article

18 Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development Cancer Treatment Reviews, December 19, 2014    Review Article

19 Role of T lymphocytes in hypertension Current Opinion in Pharmacology , December 19, 2014    Clinical Article

20 Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria British Journal of Dermatology, December 19, 2014    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharmacy